T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
York Water
YORW
$536M
| $271K | ﹤0.01% |
6,246
+90
| +1% | +$4.08K |
|
2227
Artesian Resources
ARTNA
$369M
| $270K | ﹤0.01% |
7,236
-4,178
| -37% | -$153K |
|
2228
Rockwell Medical
RMTI
$30.9M
| $269K | ﹤0.01% |
1,193
+823
| +222% | +$235K |
|
2229
HealthStream
HSTM
$849M
| $268K | ﹤0.01% |
11,183
+140
| +1% | +$3.52K |
|
2230
Daily Journal
DJCO
$828M
| $266K | ﹤0.01% |
1,163
-169
| -13% | -$44.4K |
|
|
ILPT
2231
Industrial Logistics Properties Trust
ILPT
$611M
| $265K | ﹤0.01% |
15,094
-15,505
| -51% | -$326K |
|
2232
Invesco Mortgage Capital
IVR
$805M
| $264K | ﹤0.01% |
7,751
+2,244
| +41% | +$330K |
|
|
SWN
2233
DELISTED
Southwestern Energy Company
SWN
| $264K | ﹤0.01% |
156,052
+89,900
| +136% | +$156K |
|
2234
Beazer Homes USA
BZH
$874M
| $263K | ﹤0.01% |
40,803
+12,744
| +45% | +$158K |
|
|
CNBKA
2235
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $263K | ﹤0.01% |
4,229
+1
| +0% | +$79 |
|
2236
Resideo Technologies
REZI
$3.1B
| $262K | ﹤0.01% |
54,048
-465,996
| -90% | -$4.4M |
|
|
TVTY
2237
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $262K | ﹤0.01% |
41,670
+14,944
| +56% | +$241K |
|
2238
Alaunos Therapeutics
TCRT
$4.86M
| $261K | ﹤0.01% |
710
+27
| +4% | +$14K |
|
|
PBIP
2239
DELISTED
Prudential Bancorp, Inc.
PBIP
| $261K | ﹤0.01% |
17,637
+100
| +0.6% | +$1.65K |
|
|
BNFT
2240
DELISTED
Benefitfocus, Inc.
BNFT
| $259K | ﹤0.01% |
29,052
+15,174
| +109% | +$230K |
|
|
GES
2241
DELISTED
Guess Inc
GES
| $258K | ﹤0.01% |
38,077
+11,444
| +43% | +$199K |
|
2242
Ambarella
AMBA
$3.6B
| $257K | ﹤0.01% |
+5,295
| New | +$304K |
|
2243
SunCoke Energy
SXC
$788M
| $256K | ﹤0.01% |
66,442
+13,810
| +26% | +$70K |
|
2244
Citizens
CIA
$198M
| $253K | ﹤0.01% |
38,751
+200
| +0.5% | +$1.24K |
|
|
ZEAL
2245
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $253K | ﹤0.01% |
7,331
| – | – |
|
2246
Trupanion
TRUP
$1.36B
| $251K | ﹤0.01% |
+9,656
| New | +$302K |
|
|
ACOR
2247
DELISTED
Acorda Therapeutics
ACOR
| $251K | ﹤0.01% |
2,243
+393
| +21% | +$77.4K |
|
2248
Universal Technical Institute
UTI
$1.42B
| $249K | ﹤0.01% |
+41,900
| New | +$297K |
|
|
ADMS
2249
DELISTED
Adamas Pharmaceuticals
ADMS
| $248K | ﹤0.01% |
85,739
+16,800
| +24% | +$75.3K |
|
2250
Arlo Technologies
ARLO
$1.54B
| $246K | ﹤0.01% |
101,144
+45,700
| +82% | +$159K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.